Engineered multifunctional transforming growth factor-β type II receptor ectodomain fusions for oncology applications.
Saved in:
| Title: | Engineered multifunctional transforming growth factor-β type II receptor ectodomain fusions for oncology applications. |
|---|---|
| Authors: | Lenferink AEG; Medical Devices Research Centre, National Research Council Canada, Montréal, QC, Canada., Zwaagstra JC; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada., Baardsnes J; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada., Delafosse L; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada., Parat M; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada., Iqbal U; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada., Lessard E; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada., Haqqani AS; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada., Jezierski A; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada.; Department of Medicine, Goodman Cancer Institute, McGill University, Montréal, QC, Canada., Abu-Thuraia A; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada., Tabariès S; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada., Siegel PM; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada., Sulea T; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada.; Institute of Parasitology, McGill University, Sainte-Anne-de-Bellevue, QC, Canada. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Oct 27; Vol. 15, pp. 1648779. Date of Electronic Publication: 2025 Oct 27 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41220943 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Engineered multifunctional transforming growth factor-β type II receptor ectodomain fusions for oncology applications. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lenferink+AEG%22">Lenferink AEG</searchLink>; Medical Devices Research Centre, National Research Council Canada, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Zwaagstra+JC%22">Zwaagstra JC</searchLink>; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Baardsnes+J%22">Baardsnes J</searchLink>; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Delafosse+L%22">Delafosse L</searchLink>; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Parat+M%22">Parat M</searchLink>; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Iqbal+U%22">Iqbal U</searchLink>; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Lessard+E%22">Lessard E</searchLink>; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Haqqani+AS%22">Haqqani AS</searchLink>; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Jezierski+A%22">Jezierski A</searchLink>; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada.; Department of Medicine, Goodman Cancer Institute, McGill University, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Abu-Thuraia+A%22">Abu-Thuraia A</searchLink>; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Tabariès+S%22">Tabariès S</searchLink>; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Siegel+PM%22">Siegel PM</searchLink>; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Sulea+T%22">Sulea T</searchLink>; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada.; Institute of Parasitology, McGill University, Sainte-Anne-de-Bellevue, QC, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Oct 27; Vol. 15, pp. 1648779. <i>Date of Electronic Publication: </i>2025 Oct 27 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41220943 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2025.1648779 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1648779 Titles: – TitleFull: Engineered multifunctional transforming growth factor-β type II receptor ectodomain fusions for oncology applications. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lenferink AEG – PersonEntity: Name: NameFull: Zwaagstra JC – PersonEntity: Name: NameFull: Baardsnes J – PersonEntity: Name: NameFull: Delafosse L – PersonEntity: Name: NameFull: Parat M – PersonEntity: Name: NameFull: Iqbal U – PersonEntity: Name: NameFull: Lessard E – PersonEntity: Name: NameFull: Haqqani AS – PersonEntity: Name: NameFull: Jezierski A – PersonEntity: Name: NameFull: Abu-Thuraia A – PersonEntity: Name: NameFull: Tabariès S – PersonEntity: Name: NameFull: Siegel PM – PersonEntity: Name: NameFull: Sulea T IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 10 Text: 2025 Oct 27 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |